Evolve Resources for Mosby's 2027 Nursing Drug Reference, 40th Edition

Drug categories Alpha-adrenergic blockers Anesthetics--general/local Antacids Anti-alzheimer agents Antianginals Antianxiety agents Antiasthmatics Anticholinergics Anticoagulants Anticonvulsants Antidepressants Antidiabetics Antidiarrheals Antidysrhythmics Antiemetics Antifungals (systemic) Antihistamines Antihypertensives Antiinfectives Antilipidemics Antineoplastics Antiparkinson agents Antiplatelets Antipsychotics Antipyretics Antiretrovirals Antituberculars Antitussives/expectorants Antivirals Beta-adrenergic blockers Bone resorption inhibitors Calcium channel blockers Cardiac glycosides Cholinergics Cholinergic blockers Corticosteroids Diuretics Histamine H2 antagonists Immunosuppressants Laxatives Neuromuscular blocking agents Nonsteroidal antiinflammatories Opioid analgesics Salicylates Sedatives/hypnotics Skeletal muscle relaxants Thrombolytics Thyroid hormones Vasodilators Vitamins Individual drugs in A-Z Format Appendices A. Selected new drugs B. Recent FDA drug approvals C. Ophthalmic, otic, nasal, and topical products D. Vaccines and toxoids E. Antitoxins and antivenins F. Herbal products G. Combination products H. Medications that may be inappropriate for geriatric patients I. Drugs metabolized by known P450’s J. Safety in handling chemotherapeutic agents K. High-alert drugs L. Controlled substance chart M. Immunization schedules for children and adolescents N. High-alert Canadian medications O. Canadian controlled substance chart P. Canadian recommended immunization schedules for infants and children Q. FDA pregnancy categories R. Weights and equivalents S. Abbreviations

Linda Skidmore-Roth, RN, MSN, NP, Consultant, Littleton, Colorado; Former Nursing Faculty, New Mexico State University, Las Cruces, New Mexico; El Paso Community College, El Paso, Texas, USA